Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2018

Open Access 01-12-2018 | ASO Author Reflections

ASO Author Reflections: Hematological Biomarkers of Survival in Cutaneous Melanoma

Authors: Alyss V. Robinson, MRes, Howard Peach, MBChB, BSc, FRCS(Plast), Ryckie G. Wade, MBBS, DipHR, MClinEd, MRCS, FHEA

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

The incidence of cutaneous melanoma has risen faster than any other malignancy worldwide.1 Despite decades of research into tumor biology, as well as surgical and medical treatments, melanoma remains one of the most treatment-resistant cancers. …
Literature
1.
You W, Henneberg M. Cancer incidence increasing globally: the role of relaxed natural selection. Evol Appl. 2018;11(2):140–52.CrossRefPubMed
2.
Templeton AJ, McNamara MG, Eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:124.CrossRef
3.
4.
Wade RG, Robinson AV, Lo MCI, et al. Baseline neutrophil–lymphocyte and platelet–lymphocyte ratios as biomarkers of survival in cutaneous melanoma: a multicenter cohort study. Ann Surg Oncol. 2018;25:3341–49.CrossRefPubMedPubMedCentral
5.
McKean MA, Amaria RN. Multidisciplinary treatment strategies in high-risk resectable melanoma: role of adjuvant and neoadjuvant therapy. Cancer Treat Rev. 2018;70:144–53.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Hematological Biomarkers of Survival in Cutaneous Melanoma
Authors
Alyss V. Robinson, MRes
Howard Peach, MBChB, BSc, FRCS(Plast)
Ryckie G. Wade, MBBS, DipHR, MClinEd, MRCS, FHEA
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6913-8

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue

ASO Author Reflections

ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors

Correction

Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery

ASO Author Reflections

ASO Author Reflections: Cytoreduction for Extrahepatic Metastatic Neuroendocrine Tumors

Editorial

Thank You to the Annals of Surgical Oncology Expert Reviewer Community

ASO Author Reflections

ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited

ASO Author Reflections

ASO Author Reflections: R0 Resection and Targeted Therapy for Colorectal Peritoneal Metastasis